Drug Metabolism and BBB Flashcards

(45 cards)

1
Q

Drug metabolism

A

aka “biotransformation”
the process by which enzymes in the body catalyze reactions that change the chemical structure of a drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

principal site of drug metabolism

A

liver and GI tract

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Goal of drug metabolism

A

to make drugs easier to excrete

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Phase 1 enzymes/ reactions of metabolism

A

add or create a reactive group on the drug, to create a site for a phase II enzyme to add a large polar group (e.g. oxidation, reduction, hydrolysis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Phase II reactions of metabolism

A

add a large polar group via conjugation reactions to make the drug water-soluble, easier to excrete

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Metabolic inactivation

A

most commonly, metabolism converts a pharmacologically active drug (most are lipid-soluble) to a hydrophilic form that is more readily excreted in urine, but is no longer pharmacologically active

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Metabolic bioactivation

A

some drugs are administered as a prodrug which becomes active (or more active) when metabolized. Example: cyclophosphamide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Metabolic toxicity

A

products of drug metabolism can sometimes be toxic. Example: Tylenol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Cytochrome P450 enzymes

A

aka P450s or CYPs are a very large family of enzymes that catalyze Phase I reactions; most are metabolized by CYP enzymes, especially CYP 3A4, 2D6 and 2C9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

UGTs (UDP-glucuronosyltransferase enzymes)

A

one family of enzymes that catalyzes the largest fraction of Phase II reactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

conjugation reactions

A

includes methylation, sulfonation, acetylation, glucuonidation; occurs during Phase II metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Enzyme induction

A

a process whereby a drug increases the expression of an enzyme (causes the body to make more copies of the enzyme by increasing gene transcription and expression); results in an increased metabolite production and decreased concentrations of parent or precursor drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Enzyme inhibition

A

a process whereby a drug or other chemical decreases the rate of metabolism of a substrate (most commonly, by competing for the active site on the enzyme); results in decreased production of metabolites and increased concentration of parent or precursor drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How is the exchange of chemicals between blood and CNS regulated?

A

tightly regulated by specialized endothelial or epithelial cells (termed blood-tissue barriers)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

sites with protective blood-tissue barriers

A

brain, placenta, retina, testis, thymus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

paracellular diffusion

A

extremely rare (due to tight seals between brain endothelial cells called tight junctions) so uptake of water-soluble molecules into brain is very limited by this route

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

transcellular lipid diffusion

A

allows many small lipophilic and gaseous molecules to cross brain endothelial cells into brain (most substances that enter brain enter by this route)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

lipid diffusion

A

operates along a concentration gradient; requires no energy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

measure of lipophilicity

A

LogP (the partition coefficient), measured by comparing partitioning of a compound into a lipid (octanol) vs. water layer (LogP); high logP value = highly lipophilic; low logP value = hydrophilic

20
Q

transport proteins

A

allow uptake of specific key nutrients and substrates such as amino acids and glucose

21
Q

transcytosis (receptor-mediated and absorptive)

A

involve bulk packaging of many types of substrates into vesicles for delivery across the BBB

22
Q

How do substances move in and out of the blood outside of the CNS?

A

via capillaries

23
Q

special CNS capillary structural features that strictly limit entry of fluids/water-soluble compounds into the brain

A
  1. tight junctions
  2. no fenestra (pores)
  3. few pinocytotic vesicles
  4. a net negative charge on BEC
  5. microglia near vessels
  6. thick basement membrane
  7. pericytes
  8. astrocytes
24
Q

tight junctions

A

specialized structures form a nearly impenetrable seal between endothelial cells, preventing movement of ions or molecules between endothelial cells

25
no fenestra (pores)
limits entry of small molecules and proteins
26
few pinocytotic vesicles
minimizes entry of extracellular fluid, which contains sugars and proteins
27
a net negative charge on BEC
limits entry of anions into brain
28
microglia near vessels
restrict pathogen entry into brain
29
pericytes
contractile cells that wrap around blood vessels; regulate vessel diameter and blood flow
30
astrocytes
end-feet completely surround brain vessels; they can release chemicals that alter BBB permeability within seconds
31
the biochemical elements of the BBB
enzymes and transporters
32
uptake transporters
bring molecules like glucose, lactate and certain amino acids into brain, and allow exchange of ions. e.g. GLUT1 (glucose) and LAT1 (large neutral amino acid transporter)
33
efflux transporters
bind many chemicals that would otherwise be able to penetrate into brain, and pump them back into blood. e.g. P-gp ; can also help clear waste products from brain. e.g. OAT3
34
P-glycoprotein
-most important efflux transporter at the BBB -can nearly eliminate brain penetration of strong P-gp substrates -member of ATP-binding cassette (ABC) transporter superfamily -also expressed in many organs and tissues and often over-expressed in tumors (confers resistance to antineoplastic drugs) -mediates unidirectional, active transport of many structurally diverse lipid-soluble chemicals and therapeutics from BEC into blood
35
Functions of BBB
-protects brain from exposure to toxic chemicals, infectious agents -prevents injury from swelling -somewhat limits ability of brain to sense chemical changes in blood, including endocrine signals -barrier properties substantially restrict ability to deliver drugs to CNS, making it very difficult to treat CNS diseases
36
BBB disruption in disease
several diseases are associated with damage to the BBB, which can be either a cause or consequence of these diseases (stroke, epilepsy, Alzheimer's, MS, malaria, diabetes)
37
brain tumors
brain tumors not only physically disrupt the BBB, but they form their own new vasculature, which tends to be leaky
38
Region of CNS not equally protected by BBB
circumventricular organs (CVOs); contain fenestrated capillaries, enabling certain chemo-sensory or secretory functions
39
CVOs with chemosensory functions
enable the brain to respond to changes in blood chemistry (such as area postrema)
40
CVOs with secretory functions
enable a direct pathway for neuro-endocrine communication (such as the pituitary and pineal gland)
41
choroid plexus
-a layer of ependymal cells surrounding a wad of capillaries and connective tissue; found in all ventricles -produces CSF -clears waste from brain -contains tight junctions, transporters, enzymes
42
ependyma
interface between brain tissue and CSF; a single layer of ependymal cells; has incomplete tight junctions that allow some exchange between CSF and nearby brain/spinal cord tissue
43
how come most CNS disorders are not treatable?
BBB excludes hydrophilic drugs, macromolecules, anions, and other compounds; 98% of small-molecule drugs do not cross BBB
44
restrictions for CNS therapeutics/drug development
-low MW -lipophilic -cationic non-P-gp substrates
45
drug delivery to the brain
-direct instillation of drug into brain tissue -direct instillation of drug into CSF -nasal delivery -nonselective opening of tight junctions -selective opening of tight junctions -inhibition of P-gp -colloidal carriers -molecular trojan horse approaches